Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OXTHERA INC.

Home Clinical Trial Sponsors and OrganizationsOXTHERA INC.

OXTHERA INC.

13709 Progress Blvd Ste 17, Alachua, Florida, United States

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

6

6 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

2

33.3%

Phase 3

2

33.3%

Trial Status Distribution

Active, not recruiting

4

66.7%

Not yet recruiting

2

33.3%

Clinical Trials

Trials sponsored by this organization (6)

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multi-center, International Study to Evaluate the Efficacy and Safety of Oxabact(TM) to Reduce Urinary Oxalate in Subjects with Primary Hyperoxaluria. - Study to see if Oxabact reduces urinary oxalate, the Phoenix study

Active, not recruiting

Mar 200850 participants

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multi-center, International Study to Evaluate the Efficacy and Safety of Oxabact(TM) to Reduce Urinary Oxalate in Subjects with Primary Hyperoxaluria. - Study to see if Oxabact reduces urinary oxalate, the Phoenix study

Active, not recruiting

Aug 200742 participants

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multi-center, International Study to Evaluate the Efficacy and Safety of Oxabact(TM) to Reduce Urinary Oxalate in Subjects with Primary Hyperoxaluria. - Study to see if Oxabact reduces urinary oxalate, the Phoenix study

Active, not recruiting

Jul 200742 participants

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multi-center, International Study to Evaluate the Efficacy and Safety of Oxabact(TM) to Reduce Urinary Oxalate in Subjects with Primary Hyperoxaluria. - Study to see if Oxabact reduces urinary oxalate, the Phoenix study

Active, not recruiting

Jul 200742 participants

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multi-center, International Study to Evaluate the Efficacy and Safety of Oxabact(TM) to Reduce Urinary Oxalate in Subjects with Primary Hyperoxaluria.

Not yet recruiting

An Open-label (OL) Extension Study evaluating the Long-Term Safety of OxabactTM in Subjects with Primary Hyperoxaluria (PH) who participated in the Double-Blind (DB) Efficacy Study

Not yet recruiting

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials6
Approvals
News

Back to Organizations